Zevin Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.6M | Buy |
151,340
+3,154
| +2% | +$220K | 1.52% | 29 |
|
|
2025
Q1 | $10.9M | Sell |
148,186
-4,689
| -3% | -$345K | 1.73% | 27 |
|
|
2024
Q4 | $10M | Buy |
152,875
+18,776
| +14% | +$1.23M | 1.47% | 31 |
|
|
2024
Q3 | $10.4M | Sell |
134,099
-756
| -0.6% | -$58.9K | 1.62% | 27 |
|
|
2024
Q2 | $10.5M | Buy |
134,855
+1,295
| +1% | +$101K | 1.7% | 26 |
|
|
2024
Q1 | $9.05M | Buy |
133,560
+3,794
| +3% | +$257K | 1.51% | 28 |
|
|
2023
Q4 | $8.74M | Buy |
129,766
+3,217
| +3% | +$217K | 1.57% | 26 |
|
|
2023
Q3 | $8.57M | Buy |
126,549
+3,574
| +3% | +$242K | 1.72% | 25 |
|
|
2023
Q2 | $8.8M | Buy |
122,975
+382
| +0.3% | +$27.3K | 1.77% | 26 |
|
|
2023
Q1 | $8.51M | Buy |
122,593
+17,906
| +17% | +$1.24M | 1.74% | 26 |
|
|
2022
Q4 | $7.1M | Buy |
+104,687
| New | +$7.1M | 1.54% | 30 |
|